Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites

NCT06553456 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Cirrhotic Ascites

Interventions

DRUG: Recombinant Human Serum Albumin
DRUG: Human Serum Albumin

Sponsor

Protgen Ltd